Updates are available Correction dated 2020-06-17
Click to view Correction: https://doi.org/10.1038/s41572-020-0192-y
Updates are available Correction dated 2020-04-29
Click to view Correction: https://doi.org/10.1038/s41572-020-0176-y
-
Authors
Tursi, Antonio
Scarpignato, Carmelo
Strate, Lisa L.
Lanas, Angel
Kruis, Wolfgang
Lahat, Adi
Danese, Silvio
- License Information
-
More Information
Article History
Accepted: 11 February 2020
First Online: 26 March 2020
Change Date: 17 June 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Change Date: 29 April 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: C.S. and A. Lanas are members of the Speakers’ Bureau and of the Scientific Advisory Board of Alfasigma SpA. W.K. served as speaker, consultant and/or advisory board member for Abbvie, Ardeypharm, Falk, Ferring, Genetic Analysis, Gräfe & Unze, Institut Allergosan, Nikkiso, Otsuka and Tillots. S.D. served as speaker, consultant, and/or advisory board member for Abbvie, Allergan, Alfa Wassermann, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Gilead, Hospira, Johnson and Johnson, Merck, MSD, Mundipharma, Pfizer Inc., Sandoz, Takeda, Tigenix, UCB Pharma, Vifor. The remaining authors declare no competing interests.
